Investor Overview

NASDAQ: XBIT0.314.85Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
DateTitle 
12/13/18XBiotech Announces Publication of Post-Hoc Analysis for Phase III Colorectal Cancer StudyPrinter Friendly Version
12/12/18XBiotech’s Results from Phase 2 Atopic Dermatitis Study Suggest New Drug to Treat Skin DiseasePrinter Friendly Version
12/03/18XBiotech Announces Successful Completion of GMP AuditPrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »